BKYI.OQBBio Key International INC

Form 4: BIO-KEY International CEO and Chairman Buys 5,000 Shares, Signaling Confidence

Sentiment:

Insider Transaction Report

📋All filings for Bio Key International INC
🔒Login to Follow

Michael W. DePasquale, CEO and Chairman of BIO-KEY International Inc., has acquired 5,000 shares of the company's common stock at $0.81 per share, increasing his direct beneficial ownership to 44,519 shares.

Better than expectedThe CEO and Chairman, Michael W. DePasquale, purchased 5,000 shares of the company's common stock. Insider buying is generally viewed as a positive indicator, suggesting management's confidence in the company's future prospects and valuation.

Summary

  • Michael W. DePasquale, who serves as Director, 10% Owner, Chief Executive Officer, and Chairman of BIO-KEY International Inc. (BKYI), purchased 5,000 shares of the company's common stock.
  • The transaction occurred on June 3, 2025, at a price of $0.81 per share.
  • Following this acquisition, Mr. DePasquale directly beneficially owns 44,519 shares of BKYI common stock.
  • The purchase was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
  • His reported holdings do not include options to purchase an additional 232 shares.

Sentiment

Score: 8

Explanation: The direct purchase of company stock by the CEO and Chairman signals strong insider confidence, which is a positive indicator for investors.

Positives

  • The CEO and Chairman, Michael W. DePasquale, purchased 5,000 shares of company stock, which is often interpreted as a strong signal of insider confidence in the company's future performance and valuation.
  • The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned investment strategy rather than a reactive one.

Future Outlook

N/A

Industry Context

N/A

Related Party Transactions

  • Michael W. DePasquale, the Chief Executive Officer and Chairman of BIO-KEY International Inc., purchased 5,000 shares of the company's common stock.

Stakeholder Impact

  • Shareholders: May perceive the insider purchase as a positive signal, potentially increasing confidence in the company's stock and future performance.
  • Employees/Management: Reinforces the alignment of interests between the company's leadership and its shareholders.

Key Dates

DateDescription
06/03/2025Date of earliest transaction (stock purchase by Michael W. DePasquale)

Recommendation

buy

Keywords

BIO-KEY International, BKYI, insider trading, Form 4, stock purchase, CEO, Chairman, beneficial ownership, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.